FELIX PREHN DAILY MARKET NEWS By Goat Academy

Felix Prehn - 4 Stock I’m Buying NOW Before Christmas + Stock Market News 03 November 2025 (Goat Academy)

Felix Prehn

Support the show

👉 Claim 99% Off the Financial Freedom Program. Use coupon 99PC at checkout https://felixfriends.org/stocks

SPEAKER_00:

If you're sitting on cash right now wondering where to invest this year, what might just show you could be the difference between missing out and catching some of the biggest opportunities in tech, healthcare, and AI infrastructure. Winston sort of laid down, plus um Rose and Tabitha did all the research for this, and they said to me that we had a critical moment. Four stocks across booming industries are setting up for potentially explosive moves. That's what she just said. And while most investors are chasing the same overpriced mega caps, these four opportunities are flying under the radar, and Wall Street could be quietly accumulating. So by the end of this video, you know exactly which stocks I'm buying, why these industries could be exploding, and how you can position yourself before uh the Father Christmas rally. My name is Felix Bring, this is Rose, this is Taberfell. I'm an ex-investment banker who's seen how institutional money moves. I'm also the founder of the GOAT Academy with over 20,000 students learning to do better for themselves. I'm also the co-founder of Trade Vision, where we make the latest market news and data available to you. And my mission is to spend my retirement usefully to help you make better decisions. Well, this kitten seems to be on some sort of suicide mission off this desk. So we're going to break down four stocks across four different sectors: data storage, AI infrastructure, medical devices, and biotech. And these aren't random picks. Each one is positioned in an industry that's experiencing massive tailwinds. I'm going to have to put Tabitha off the table here because she seems a little distressed. Now, this is not financial advice. I'm sharing my research, so much I'm personally looking at. Always do your own due diligence and consult with advisors and so on. You want to make decisions based on your rules and your framework and your risk, not what some guy and his cats on YouTube are looking at. If you want to get started on that, I will do one better for you, even than these four stock picks. And I'm not going to hold you hostage, I'll tell you what the tickets are in a sec. I'll give you the three rules that Wall Street uses to find better stocks. And that's a separate video. It's 15 minutes long. I've compressed like literally a decade of knowledge into that, and you can get access to that at feedixfriends.org slash get free. And if you want to get all the details of all the stocks that we're looking at here, I'll also put a research report live in our private community on WAP, which is free, by the way. And you get access to tons of amazing stuff and tools and so on, plus I don't know, six, seven, eight thousand amazing people. And of course, Rose, she's also in there. She's you know in charge of the whole thing. Now, what are the mega trends driving these stocks? The first trend is the AI data explosion. AI is eating the world, and I don't mean that as hype, I mean literally every AI model, every chat GPT query, every autonomous vehicle, every smart device, they all need one thing: massive amounts of data storage. We're talking about data centers consuming 10 to 12% of all US electricity, growing at 20% per year. Now, it's also going to use 175 zettabytes of global data. Now, Winston wrote down a research note for me here that that is apparently 175 trillion gigabytes, and that makes it somehow easier to comprehend. I still don't know what the heck that means, but it's a lot of data. That's what that means. Now the second trend is cloud computing. It's accelerating the growth. Market is forecast to hit 738 billion, not by 2040, by 2025, like now. Companies are spending billions building this AI infrastructure, but they're all racing to build more. It creates a massive opportunity in two areas. The company's storing all that data, and the companies housing the infrastructure. And then the third trend is healthcare. Healthcare is literally going through a revolution. We've got an aging population, chronic diseases because everyone eats the wrong food, and um, it's full of drugs, and technology is catching up. So the medical device market is projected to hit$600 billion by this year. And home care is exploding. People want treatments they can do from their living room, not in a hospital. And in biotech, we're seeing breakthroughs in cancer treatment, rare diseases, personalized medicine, and so on. Again, a huge opportunity. So those are the big waves. Now let me show you the four stocks that I think are positioned to ride them. The first stock here is WDC, Western Digital. Yeah, they make you know hard drives and so on. It's an infrastructure play. And it's already an absolute tear. It's up 200% year over year. So before we go into the fundamentals here, let's start by actually looking at that stock chart. I am using TradeVision here, which is a tool that we built. It gives you amazing news and everything else and alerts and incredible indicators. But what am I seeing here right now? Well, if you've watched that 15-minute video at FelixFrence.org slash get three that I keep banging on about, you will see, you will see a pattern, right? And you will then say, well, somewhere here was a sweet spot entry point. It looks like we're going higher. Volume has exploded. That's a check. So yes, it has gone up a lot already, but it looks like it wants to go up a lot higher. Why? Because the big money, the Wall Street money, appears to be buying more of it. But to really understand this, you need to understand that Western Digital makes hard disk drives and nano or flash storage. Sounds boring, right? But here is what's not boring. Hey, I need somewhere to store all the data. Think about it. Every time you use Chat GPT, every time a self-driving car processes information, every time a hospital stores medical imaging, that data has to live somewhere. And the data storage market is projected to grow from 250 billion right now, which is not exactly chunk change, to 480 billion by 2030. That's 14% growth per year just for the sector. So if you're a better company in that, you have a potential to gain more than 14% a year. You see where I'm coming from? And maybe you're a techie and you think, I don't know, everybody wants SSDs. It's true, they're faster. I just bought a laptop with a four terabyte SSD. Cost me three arms and one leg, but it's very, very quick. But for data storage, HDDs are still king. Why? They're cheaper, they're more reliable for long-term storage, and they are what hyperscale data centers use. So they're basically two people there: Western Digital and Seagate. They have a diopoly in this market. They're literally only two players left. And if you look at WDC's recent performance, they're crushing it. Revenues up 27%, profits per share up 137%, and they beat both revenue and profit expectations. So as the AI infrastructure build-out continues, and we're just getting started here, that's the ball case. They have pricing power because they're only two companies in this space, and they also pay a pretty nice dividend, which they just raised by 25% because they've got more cash and then they want to do with, which is not bad if you're an investor. And on top of that, their customers, you know, Amazon, Microsoft, Google, they have purchased orders out through 2027. So it means Western Digital has visibility into demand for the next two years, which is huge, because this is a cyclical business. This is not a buy forever kind of stock. They're also investing a billion dollars into Japan to enhance production for exactly these AI loads and analysts. So price targets keep going up and up and up and up and up. Let me see if we can find some of them here in the in the news section. Analyst price upgrades, Cancellus, Gerald, Tidd Cohen, Jamie Wong, Barkley, Smitsuo, all up to$200, citing potentially strong demand. By the way, you can get those notifications on your phone as well. All you've got to do is uh set up your news alerts in the Trade Vision app. So we're trading at 150. Analysts are loons in my opinion. I don't care particularly about their opinion, but yeah, I think it has nice upside. Now, are there risks? Yes. It's a cyclical industry. There are risks with every investment. So come to your own conclusion. Don't listen to kittens and golden retrievers. Now, if you're thinking, okay, this sounds interesting, but it's a bit complicated. I still don't fully know where I'm buying, where I'm selling, and so on, what the rules are. Look, let me do this for you. If you're interested in being coached by my mentors, literally the guys that I talk to, the guys that I've learned from, I'm gonna give you the opportunity to potentially learn from. You've got to be serious about investing. And what you can do is you can book a free strategy call with my team at phoenixrends.org slash freedom, and you're gonna have a chat with my team about what it would look like if you were learning from my mentors, what our mentorship programs look like, and so on. Zero pressure. You just have to be in a frame of mind where you are open to the idea of actually learning from people who've done this 10, 20, 30 years on uh on Wall Street and the big investment banks. So if you want to do that, go to FelixFrance.org slash freedom and grab yourself a free strategy call with my team as we move on to stock Nurodu. We're still in the AI world. The data center REIT of all REITs, EQIX, it's called, it's a picks and shovels play on the AI boom. You know the old saying from the gold rush, the people who made the most money weren't the miners, um, it's the ones who were selling picks and shovels. And Equinex, Equinix even is selling the shovels. They even operate data centers where the magic happens. So every cloud service, every AI model, every streaming platform, they all run data centers. Equinox, Equinix even, there used to be a nightclub called Equinox. I think that's where the where the mind wanders in London. Um, I think it was a terrible place, I vaguely remember. But anyway, um was that where was that center? If somebody remembers that, my mind seems to be at fuzzy on a particular decade. But it's in the comments down below. But yeah, they're in 71 markets worldwide, they're the largest data center REIT in the world. Their business model is rather beautiful. Companies lease space. So this is basically how it works. So you have a customer, so a company, they will lease space on long-term contracts. It's predictable recurring revenue, and then that company pays to put data center service in there and everything else, and it's their responsibility in EQIX, Equinix just collects the rent. The landlord of the AI revolution. Now, the real kicker with data centers is that they're using so much energy. Why they use so much energy? Because they control, they create so much, well, heat and they need to be cooled and so on. So, what Equix is doing is they're building data centers that already have cooling and power infrastructure needed in place. So it's not like you can just go and rent a random warehouse and put your service in there. No, you need the infrastructure around it. And if you look at their fundamentals, actually, before we do that, let's have a quick look at the stock chart. Because you you you always got to look at this. It's always nice to zoom out a little bit. And you can see that, yeah, this thing was at one point trading at about$1,000. It's about 15% below that. But what do we see for my friends who understand the rules? Well, you see that you have your sort of heartbeat pattern where it goes sideways for quite a long period of time. So at here is where we start to get interested, and we're like, you know, goggle-eyed, going, ooh, this looks interesting out of the watch list. And then that purple line there is the 150-day moving average line, at which point it becomes investable, breaks out above it. Maybe we bought some here, pulls back, bounces off the yellow 50-day moving average line, and I'm going a little bit quick here, and then it recovers very, very nicely. And right now it's literally at the on the on the cusp there of breaking out, volume is picking up, um, indicators are starting to look better. So we're kind of liking where it's sitting. Doesn't mean you should run out and buy it. You're gonna want to learn these things. And the best way to do that, by the way, is literally one-on-one. Like just have someone look over your shoulder as you're doing what you're doing, um, who has done this for institutions. So if you're interested in that potentially, go and book yourself a free call with my team to learn what our mentorship program is all about. FelixFriends.org slash freedom is the link down below. But if you look at their earnings, they had a supported$2.3 billion in revenue, which is pretty solid growth. They achieved um the highest gross bookings, 25% up on the year. They pay a 2.2% dividend, which is not bad if you're a dividend uh chaser. And we basically have this multi-decade AI infrastructure track, likely. Global footprint, big brand, um, massive expansion, and just a market that's grown. And that 15 billion there is to build hyperscale data centers in the US. So massive, massive, massive expansion there coming from them. Now, REITs have an advantage, but it's a real estate investment trust, right? So it means they have to pay out, they must pay out 90% of taxable income as dividends. So for investors, that means steady income. For the company, it means tax advantages. REITs tend to be a little bit less volatile than pure tech stocks, but they're not immune to market swings. Obviously, do your research, um, understand the risk. Um, but what I like is that in my opinion, these guys have a moat. By that I mean that sort of secret weapon, interconnection. They don't just rent out space, they connect companies directly to each other within their facility. So if you're a business that needs low latency access to AWS, Azure and Google, you can get all three in literally one Equinix data center. And that creates a network effect. The more companies are in the ecosystem, the more valuable that ecosystem becomes. Analysts seem to also like it, not that I pay particular attention to that. Are there some risks? Yeah, there were some foreign currency exchange impacts. Um, data centers are very capital intensive. You need lots of upfront investment. Um, and and energy costs are rising, and that could put some pressure on them. Um, plus, there's also competition. There is another REIT uh called uh Digital Realty Trust, uh, and there's some other REITs out there, of course, as well. But I like the I like the setup. I like the potential breakout that we're seeing here if we understand the child patterns there and all that. Again, I'd recommend you come and learn with somebody who knows what they're talking about. Um you can start with us if you like, Felix Frensenorgslash Freedom. Now, stock numerous is TCND, tactile medical. So we shift it into healthcare. This is a small cap medical device company. Small cap's always more risky, just bear that in mind. It's flying completely under the radar, but it's positioned in a growing market with some really interesting tailwinds. The they treat lymphedomidema. I don't even know how you pronounce that. What is it? Well, lymphedema is um apparently something most people don't ever heard of, including me. It's a chronic condition where fluid builds up in your body, usually in your arms and legs, and it causes swelling. It's often a side effect of cancer treatments and other horrendous things. And there are apparently 140 million to 250 sad souls in the world that suffer from this. For example, in the US, 27% of breast cancer survivors develop this Lib for whatever disease uh condition. It's uncomfortable, it's um, and there have been very limited treatment options. So that market alone is expected to grow to 1.4 billion, so more than double over the next five years. That's about 10% a year growth, aging populations, rising cancer rates, uh, and all of that. And you know, you've got to look after your own health. That's the first thing. Don't rely on pharma to fix it for you. But these companies will make money, it doesn't mean we shouldn't take part of that. So they make this at-home pneumatic compression device. Normally you have to go to a hospital for that, and it's called Flexi Touch. It's sort of like a high-tech massage sleeve that you wear at home, and then it uses air pressure to move, reduce sweating, basically. It's also very unpleasant. But um, go and go and see an alternative medicine practitioner, that's what I would say to start with. But apparently you can also do this. And look, healthcare is shifting to the home. It's more convenient, it's more cost effective. People like it. Patients prefer to sit at home in their armchair, keep eating the crisps and drinking the Coca-Cola and watching Netflix and wondering why they're unhealthy. Judgmental here, right? No, of course, people have medical things for all sorts of reasons. Just saying, take responsibility for your health and good things will happen likely. But in the meantime, we can potentially make some money out of these guys. So if we look at their chart first, no sarcasm here whatsoever. Their chart shows you something kind of interesting. This thing, buy and hold, they say, right? Imagine you're held up here. You'd still be down 79, 80% right now. So we don't buy and hold forever. That's good. You know, you do that with the index, with individual stocks. It's madness, in my humble opinion. Um, so what are we seeing here? Well, we're seeing a really nice uptrend. That, well, first of all, we saw our textbook consolidation down here. We broke out with a gap up, monstrous volume. That was the uh pay attention to this, pull back a little bit, second chance, and then we are grinding our way up very, very nicely with the occasional bit of excitement, after which there's a pullback, a little more excitement, but we're now breaking out of that, you know, what is that six-month high here potentially? So we break out of this high here, and I'm very, very interested. Now, earnings are coming up, so that's a risk factor to take into account here. But you look at their last set of numbers, revenue was up 8% over the year, uh, product sales on Airways was up 52%, gross margin is now 74 to 75%, which is pretty extraordinary. And it's a market that's growing with limited competition, and home care is growing, margins are improving, so we like it. I just hope that you don't have these conditions, you never have to buy their thing. But um as investors, we kind of like it. Does Wall Street say anything about this? Chairs trading higher. Hang on, I got impactful news on only. Let me see the rest of it. New six-month clinical data out, um, coverage initiated with a buy rating and so on. So, yeah, there is some, there's some positive noise around this stock generally. But it's a small market cap stock. Market caps are only by three or odd million, so it means higher volatility. And there has been some insider selling. Now, insider sell for all sorts of reasons, you know, New York, new house, third mistress, you know, uh demanding golden retriever who wants more treats. Uh but um bear in mind the risks, right? I like it. Doesn't mean you should. It should mean it probably means you should start doing your research. Um, one place you can do that is if you download the research report I made for you, and then don't just rely on that either. The fourth stock is a biotech company called CYTK. Now, there should be a warning sign that comes with this. This may damage your financial health. This is high risk. Why? Because these biotech companies are. Now, the biotech industry is expected to grow about 12% per year for the next 10 years or so. So if you're a better than average biotech company, potentially you can deliver some truly outsized life-changing returns, but it could also make you bankrupt by tomorrow if you put all your money into it. So let's have a look at the stock chart then. And what do you see? Well, first of all, zoom out and see where this thing has been. So at the moment it's trading about 40% or below its all-time high. And what do you see when you look at the stock chart here in TradeVision? Well, the first thing I see is that we had a consolidation phase down here. That's always the consolidation pattern that we see again and again and again. It broke out here on tremendous volume, and that was your buy opportunity number one. Too late, I know. And then we rallied even higher, we pulled back again. That tends to happen. Profit taking and second opportunity. We break out again, that here becomes the second opportunity. This is just rules-based. And then we pull up even higher, we pull back a little bit here again, shake out some of the um people who wanted to get out. And what are we seeing right now? What it looks like we're breaking out again, and it could be opportunity number test. Right? So that's the setup here. Warning, earnings are coming up. That adds a little bit of extra um noise there and risk. What do they do? They are a biopharma company. They develop muscle activators and muscle inhibitors as a potential treatment for people with diseases characterized by impaired or declining muscle function. Anything but the gym. I'm kidding. I get it's a medical condition, all right? Just kidding here. Um a little bit of revenue, very little losing money. You'd expect them to be there. So it is an early stage company, therefore, it has potentially a hack of a lot of risk. But the money to me seems to be paying attention, which is why we're seeing this nice trend up. And that's basically why I'm watching this. So, for me, biotech is a sector that I want to be in because it's made me a lot of money, but you've got to come to your own conclusion here. And you've got to have some risk management rules. So, let me give you some thoughts on portfolio strategy, not advice, just some rules. Most of your money should be in solid, lower risk investments, and you can put some of it into a higher reward place. How much depends on where you are in life, what your income streams are, and so on. Um, I've got the wrong ticker here, CYTK. Um, so generally speaking, a sort of 3 to 5% in something for a solid company or you know, an ETF is usually better. And then the higher risk you go, the smaller allocations get. And again, not financial advice, not telling you to buy these percentages. I'm just saying if you were going to do something with it, think about frameworks for risk, which is what this is all about. So I teach people to use stop losses, especially for small caps. We cut our losses quickly, we let the winners run, we don't chase rallies, we get rid of FOMO, and yes, we use technical analysis. Why? Because it shows us what the money is doing, where the big money is flowing. And I care a lot about that because ultimately I can be right about the stock. But if Walt Street disagrees with me, well, it's going to be very, very hard to ever make money on that. So if you want to learn more about that, then do some more risk research on these guys. Again, wrong tick up. And learn how to find opportunities. Learn how to manage your risk. Have a rulebook on your desk, a piece of paper that tells you precisely what's going on, automate all your risk management, and build the confidence and the skill to manage your money better. Or at least be able to have better conversations with your financial advisor because you now know what he's talking about. So go to freedrixfrans.org slash freedom if you want to book a direct free strategy call with my team. They'll walk you through how our mentoring program works. We teach one on one. You learn from invest in bankers who are retired, hedge fund managers who are retired. No prior knowledge is required, zero skill is required. All that's required is a desire to learn and improve those skills. If you got some value out of this video, share it with a friend. All the best.